Search This Blog

Monday, December 9, 2019

Regeneron down 5% after hours on possible sale of Sanofi stake

Regeneron Pharmaceuticals (NASDAQ:REGN) slips 5% after hours on light volume in reaction to reports that alliance partner Sanofi (NASDAQ:SNY) may sell its stake in the biotech.
Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)